Home › Premarket Biotech Digest: GBIM Soars On Celgene Deal, Superbugs, 3-D Printed Drugs
 

Keywords :   


Premarket Biotech Digest: GBIM Soars On Celgene Deal, Superbugs, 3-D Printed Drugs

2015-08-06 08:43:03| Biotech - Topix.net

As my favorite American sitcom character Raymond told his wife Debra, "You zig, I zag"; superbugs are now developing entirely new mechanisms to resist standard antibacterial treatment. The so-called last resort antibiotic group, called carbapenems, were developed in the 1980s and it was thought that the war against bacterial infection was won.

Tags: deal printed drugs digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
More »